As shown, non-coding areas in genes without known alterations in breast cancer such as TERT were fairly preserved in matched samples; by contrast, polymorphisms in genes like MDM2, CDKN2A, EGFR, GATA3 and mutations in frequently affected genes such as in TP53 were frequently not recapitulated. This evidence concerns the gene MDM2 and breast carcinoma.